• Posted On Saturday, October 10, 2020 by Evan Lamolinara

    Pharmaq32020

    SalesLeads announced today the Q3 2020 results for the new planned capital project spending report for the Pharmaceutical and BioTech industry. The Firm tracks North American planned industrial capital project activity including facility expansions, new plant construction and significant equipment modernization project. Research confirms 96 new projects in the Pharmaceutical sector.

    Planned industrial project activity within the sector is up 6% YTD over the previous year.

    The following are selected highlights on new Pharmaceutical industry construction news.

     

    Pharmaceutical - By Project Type

                Manufacturing/Processing Facilities - 68 New Projects

                Laboratory Facilities - 28 New Projects

                Distribution and Industrial Warehouse - 22 New Projects

               

    Pharmaceutical - By Project Scope/Activity

                New Construction - 29 New Projects

                Expansion - 37 New Projects

                Renovations/Equipment Upgrades - 44 New Projects

                Plant Closing - 1 New Project

     

    Pharmaceutical - By Project Location(Top 5 States)

                Indiana - 8

                Massachusetts - 8

                Texas - 8

                California - 7

                North Carolina - 6

     

    Largest Planned Project

    During the 3rd quarter of 2020, our research team identified 2 new Pharmaceutical facility construction projects with an estimated value of $100 million or more.

    The largest project is owned by Agilent Technologies, who is planning to invest $150 million for a 25,000 sf expansion and equipment upgrades at their processing facility in FREDERICK, CO. They expect to be operational in late 2022.

     

    Top 5 Tracked Pharmaceutical Projects

    MAINE:

    Medical equipment mfr. is planning to invest $51 million for an expansion and equipment upgrades of their manufacturing facilities in GUILDFORD, ME and PITTSFIELD, ME.

     

    NORTH CAROLINA:

    Biotechnology company is planning to invest $83 million for the construction of a 100,000 sf processing and laboratory facility at Research Triangle Park in DURHAM, NC.

     

    NEBRASKA:

    Medical device mfr. is planning to invest $70 million for the expansion and equipment upgrades of their manufacturing facility in BROKEN BOW, NE. They have recently received approval for the project.

     

    NEW HAMPSHIRE:

    Medical device mfr. is planning to invest $38 million for an expansion and equipment upgrades on their laboratory and manufacturing facility in KEENE, NH. They have recently received approval for the project.

     

    PENNSYLVANIA:

    Dental implant mfr. is planning to invest $25 million for the construction of a 235,000 sf manufacturing, warehouse, and office facility at 85 Ben Fairless Dr. in FALLS TOWNSHIP, PA. They have recently received approval for the project.

     

    Since 1959, SalesLeads, based out of Jacksonville, FL has been providing Industrial Project Reports on companies that are planning significant capital investments in their industrial facilities throughout North America. Our professional research team identifies new construction, expansion, relocation, major renovation, equipment upgrades, and plant closing project opportunities so that our clients can focus sales and marketing resources on the target accounts that have an impending need for their products, services, and indirect materials.

    Each month, our team provides hundreds of industrial reports within a variety of industries, including:

    Try It Free


    Comment